NADPH oxidase inhibition ameliorates Trypanosoma cruzi-induced myocarditis during Chagas disease

Journal of Pathology

Volumn 225, Issue 4, 2011, Pages 583-596

  Dhiman, Monisha ^a   Garg, Nisha Jain ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

apocynin; Chagas disease; inflammation; NADPH oxidase; reactive oxygen species; Trypanosoma cruzi

Indexed keywords

APOCYNIN; CYTOKINE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CHAGAS DISEASE; CONTROLLED STUDY; ENZYME INHIBITION; HEART HYPERTROPHY; HEART MUSCLE CELL; IMMUNE RESPONSE; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PHAGOCYTE; PRIORITY JOURNAL; SPLEEN CELL; TRYPANOSOMA CRUZI;

ANIMALS; CELL ENLARGEMENT; CHAGAS CARDIOMYOPATHY; CYTOKINES; DISEASE MODELS, ANIMAL; HEART; HOST-PARASITE INTERACTIONS; HYPERTROPHY; MALE; MICE; MYOCARDIUM; MYOCYTES, CARDIAC; NADPH OXIDASE; PARASITE LOAD; REACTIVE OXYGEN SPECIES; RECEPTOR CROSS-TALK; SPLEEN; T-LYMPHOCYTES; TRYPANOSOMA CRUZI;

EID: 80052181301     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2975     Document Type: Article

References (54)

1. Higuchi Mde L, Benvenuti LA, Martins Reis M, et al., Pathophysiology of the heart in Chagas' disease: current status and new developments. Cardiovasc Res 2003; 60: 96-107.
2. Tostes S Jr, Bertulucci Rocha-Rodrigues D, de Araujo Pereira G, et al., Myocardiocyte apoptosis in heart failure in chronic Chagas' disease. Int J Cardiol 2005; 99: 233-237.
3. Zacks MA, Wen J-J, Vyatkina G, et al., An overview of chagasic cardiomyopathy: pathogenic importance of oxidative stress. Ann Acad Bras Cienc 2005; 77: 695-715.
4. Cardoni RL, Antunez MI, Morales C, et al., Release of reactive oxygen species by phagocytic cells in response to live parasites in mice infected with Trypanosoma cruzi. Am J Trop Med Hyg 1997; 56: 329-334.
5. Leon JS, Wang K, Engman DM,. Captopril ameliorates myocarditis in acute experimental Chagas disease. Circulation 2003; 107: 2264-2269.
6. Piacenza L, Alvarez MN, Peluffo G, et al., Fighting the oxidative assault: the Trypanosoma cruzi journey to infection. Curr Opin Microbiol 2009; 12: 415-421.
7. Weintraub NL,. Nox response to injury. Arterioscler Thromb Vasc Biol 2002; 22: 4-5.
8. Wang HD, Johns DG, Xu S, et al., Role of superoxide anion in regulating pressor and vascular hypertrophic response to angiotensin II. Am J Physiol Heart Circ Physiol 2002; 282: H1697-H1702.
9. Griendling KK,. Novel NAD(P)H oxidases in the cardiovascular system. Heart 2004; 90: 491-493.
10. Bedard K, Krause KH,. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007; 87: 245-313.
11. Bataller R, Schwabe RF, Choi YH, et al., NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest 2003; 112: 1383-1394.
12. Babior BM, Lambeth JD, Nauseef W,. The neutrophil NADPH oxidase. Arch Biochem Biophys 2002; 397: 342-344.
13. Piacenza L, Peluffo G, Alvarez MN, et al., Peroxiredoxins play a major role in protecting Trypanosoma cruzi against macrophage- and endogenously-derived peroxynitrite. Biochem J 2008; 410: 359-368.
14. Alvarez MN, Peluffo G, Piacenza L, et al., Intraphagosomal peroxynitrite as a macrophage-derived cytotoxin against internalized Trypanosoma cruzi: consequences for oxidative killing and role of microbial peroxiredoxins in infectivity. J Biol Chem 2011; 286: 6627-6640.
15. Plata F, Garcia Pons F, Eisen H,. Antigenic polymorphism of Trypanosoma cruzi: clonal analysis of trypomastigote surface antigens. Eur J Immunol 1984; 14: 392-399.
16. Paterniti I, Galuppo M, Mazzon E, et al., Protective effects of apocynin, an inhibitor of NADPH oxidase activity, in splanchnic artery occlusion and reperfusion. J Leukoc Biol 88: 993-1003.
17. Wen JJ, Vyatkina G, Garg N,. Oxidative damage during chagasic cardiomyopathy development: role of mitochondrial oxidant release and inefficient antioxidant defense. Free Radic Biol Med 2004; 37: 1821-1833.
18. Lopez-Huertas E, Corpas FJ, Sandalio LM, et al., Characterization of membrane polypeptides from pea leaf peroxisomes involved in superoxide radical generation. Biochem J 1999; 337: 531-536.
19. Wen JJ, Garg NJ,. Mitochondrial generation of reactive oxygen species is enhanced at the Q(o) site of the complex III in the myocardium of Trypanosoma cruzi-infected mice: beneficial effects of an antioxidant. J Bioenerg Biomembr 2008; 40: 587-598.
20. Garg N, Popov VL, Papaconstantinou J,. Profiling gene transcription reveals a deficiency of mitochondrial oxidative phosphorylation in Trypanosoma cruzi-infected murine hearts: implications in chagasic myocarditis development. Biochim Biophys Acta 2003; 1638: 106-120.
21. Dhiman M, Nakayasu ES, Madaiah YH, et al., Enhanced nitrosative stress during Trypanosoma cruzi infection causes nitrotyrosine modification of host proteins: implications in Chagas' disease. Am J Pathol 2008; 173: 728-740.
22. Byrne JA, Grieve DJ, Bendall JK, et al., Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ Res 2003; 93: 802-805.
23. Kang BY, Khan JA, Ryu S, et al., Curcumin reduces angiotensin II-mediated cardiomyocyte growth via LOX-1 inhibition. J Cardiovasc Pharmacol 2010; 55: 176-183.
24. Bhatia V, Sinha M, Luxon B, et al., Utility of Trypanosoma cruzi sequence database for the identification of potential vaccine candidates: in silico and in vitro screening. Infect Immun 2004; 72: 6245-6254.
25. Garg NJ, Gerstner A, Bhatia V, et al., Gene expression analysis in mitochondria from chagasic mice: alterations in specific metabolic pathways. Biochem J 2004; 381: 743-52.
26. Gupta S, and, Garg NJ,. Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice. PLoS Negl Trop Dis 2010; 4: e797.
27. Nakamura K, Fushimi K, Kouchi H, et al., Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. Circulation 1998; 98: 794-799.
28. Pimentel DR, Amin JK, Xiao L, et al., Reactive oxygen species mediate amplitude-dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes. Circ Res 2001; 89: 453-460.
29. Murdoch CE, Zhang M, Cave AC, et al., NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure. Cardiovasc Res 2006; 71: 208-215.
30. Cave AC, Brewer AC, Narayanapanicker A, et al., NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal 2006; 8: 691-728.
31. Fielitz J, Hein S, Mitrovic V, et al., Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve disease. J Am Coll Cardiol 2001; 37: 1443-1449.
32. Wassmann S, Nickenig G,. Pathophysiological regulation of the AT1-receptor and implications for vascular disease. J Hypertens Suppl 2006; 24: S15-S21.
33. Silva GK, Gutierrez FR, Guedes PM, et al., Cutting edge: nucleotide-binding oligomerization domain 1-dependent responses account for murine resistance against Trypanosoma cruzi infection. J Immunol 2010; 184: 1148-1152.
34. Lipinski S, Till A, Sina C, et al., DUOX2-derived reactive oxygen species are effectors of NOD2-mediated antibacterial responses. J Cell Sci 2009; 122: 3522-3530.
35. Kayama H, Takeda K,. The innate immune response to Trypanosoma cruzi infection. Microbes Infect 2010; 12: 511-517.
36. de Meis J, Morrot A, Farias-de-Oliveira DA, et al., Differential regional immune response in Chagas disease. PLoS Negl Trop Dis 2009; 3: e417.
37. Munoz-Fernandez MA, Fernandez MA, Fresno M,. Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-alpha and IFN-gamma through a nitric oxide-dependent mechanism. Immunol Lett 1992; 33: 35-40.
38. Melo RC, Fabrino DL, D'Avila H, et al., Production of hydrogen peroxide by peripheral blood monocytes and specific macrophages during experimental infection with Trypanosoma cruzi in vivo. Cell Biol Int 2003; 27: 853-861.
39. Cuervo H, Pineda MA, Aoki MP, et al., Inducible nitric oxide synthase and arginase expression in heart tissue during acute Trypanosoma cruzi infection in mice: arginase I is expressed in infiltrating CD68+ macrophages. J Infect Dis 2008; 197: 1772-1782.
40. Silva EM, Guillermo LV, Ribeiro-Gomes FL, et al., Caspase-8 activity prevents type 2 cytokine responses and is required for protective T cell-mediated immunity against Trypanosoma cruzi infection. J Immunol 2005; 174: 6314-6321.
41. Miyahira Y,. Trypanosoma cruzi infection from the view of CD8+ T cell immunity-an infection model for developing T cell vaccine. Parasitol Int 2008; 57: 38-48.
42. Cave A, Grieve D, Johar S, et al., NADPH oxidase-derived reactive oxygen species in cardiac pathophysiology. Philos Trans R Soc London Ser B Biol Sci 2005; 360: 2327-2334.
43. Huang H, Petkova SB, Cohen AW, et al., Activation of transcription factors AP-1 and NF-kappa B in murine chagasic myocarditis. Infect Immun 2003; 71: 2859-2867.
44. Butterfield DA, Koppal T, Howard B, et al., Structural and functional changes in proteins induced by free radical-mediated oxidative stress and protective action of the antioxidants N-tert-butyl-alpha-phenylnitrone and vitamin E. Ann N Y Acad Sci 1998; 854: 448-462.
45. Marnett LJ,. Oxyradicals and DNA damage. Carcinogenesis 2000; 21: 361-370.
46. Wen JJ, Dhiman M, Whorton EB, et al., Tissue-specific oxidative imbalance and mitochondrial dysfunction during Trypanosoma cruzi infection in mice. Microbes Infect 2008; 10: 1201-1209.
47. Godsel LM, Leon JS, Engman DM,. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists in experimental myocarditis. Curr Pharm Des 2003; 9: 723-735.
48. Reis DD, Jones EM, Tostes S Jr, et al., Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes. Am J Trop Med Hyg 1993; 48: 637-644.
49. Moore RE, Navab M, Millar JS, et al., Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation. Circ Res 2005; 97: 763-771.
50. Wen JJ, Gupta S, Guan Z, et al., Phenyl-alpha-tert-butyl-nitrone and benzonidazole treatment controlled the mitochondrial oxidative stress and evolution of cardiomyopathy in chronic chagasic rats. J Am Coll Cardiol 2010; 55: 2499-2508.
51. Bartlett EJ, Lenzo JC, Sivamoorthy S, et al., Type I IFN-beta gene therapy suppresses cardiac CD8+ T-cell infiltration during autoimmune myocarditis. Immunol Cell Biol 2004; 82: 119-126.
52. Liu YY, Cai WF, Yang HZ, et al., Bacillus Calmette-Guerin and TLR4 agonist prevent cardiovascular hypertrophy and fibrosis by regulating immune microenvironment. J Immunol 2008; 180: 7349-7357.
53. Hoemann CD,. Molecular and biochemical assays of cartilage components. Methods Mol Med 2004; 101: 127-156.
54. Altieri P, Brunelli C, Garibaldi S, et al., Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure. Eur J Clin Invest 2003; 33: 648-656.